{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T10:45:18Z","timestamp":1789901118387,"version":"4.0.1"},"reference-count":39,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2017,12,6]],"date-time":"2017-12-06T00:00:00Z","timestamp":1512518400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American J Hematol"],"published-print":{"date-parts":[[2018,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Treatment of indolent B\u2010cell non\u2010Hodgkin lymphomas (iNHL) of renal significance is challenging given the need for deep and prolonged hematological response to restore and control renal function overtime, yet to be balanced with the risk of adverse drug\u2010related events. This prospective single\u2010center study included 20 patients with iNHL of renal significance (tubulointerstitial presentation [<jats:italic>n<\/jats:italic>\u2009=\u20098], glomerulopathy with or without monoclonal Ig deposits [<jats:italic>n<\/jats:italic>\u2009=\u200912]) who received a steroid\u2010sparing regimen of rituximab plus bendamustine (BR), with either no or &lt;1 month of steroid intake (as a first line therapy in 80%). Seventeen patients (85%) achieved a complete (CHR, <jats:italic>n<\/jats:italic>\u2009=\u200912) or a partial (PHR, <jats:italic>n<\/jats:italic>\u2009=\u20095) hematological response. Nine out of the 12 patients (75%) with iNHL\u2010related glomerulopathy had a complete (CRR) or a partial (PRR) renal response. Among the six patients with glomerulopathy and CHR, five had a CRR (83%) compared to 1\/6 (17%) that did not reach CHR. eGFR increased from 38 to 58 mL\/min\/1.73 m<jats:sup>2<\/jats:sup>, and returned to baseline in five patients. Among the eight patients with a tubulointerstitial presentation, six (75%) had a renal response (5 CRR), and eGFR increased from 29 to 48 mL\/min\/1.73 m<jats:sup>2<\/jats:sup>. One patient with a PHR had a renal relapse. Mortality rate was 10% at 12 months. The BR regimen was well tolerated overall. Thus, despite severe renal disease at presentation, a relapsing iNHL in 20% of patients and several comorbidities, the BR regimen was efficient and safe in our series. It should be further assessed as a first line therapy for patients with iNHL of renal significance.<\/jats:p>","DOI":"10.1002\/ajh.24984","type":"journal-article","created":{"date-parts":[[2017,11,23]],"date-time":"2017-11-23T08:42:40Z","timestamp":1511426560000},"page":"356-362","source":"Crossref","is-referenced-by-count":8,"title":["Bendamustine plus rituximab for indolent B\u2010cell lymphoma of renal significance"],"prefix":"10.1002","volume":"93","author":[{"given":"David","family":"Ribes","sequence":"first","affiliation":[{"name":"D\u00e9partement de N\u00e9phrologie et Transplantation d'organes Centre Hospitalier Universitaire de Toulouse  France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne E. L.","family":"Hachem","sequence":"additional","affiliation":[{"name":"D\u00e9partement de N\u00e9phrologie et Transplantation d'organes Centre Hospitalier Universitaire de Toulouse  France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie","family":"Oberic","sequence":"additional","affiliation":[{"name":"Service d'H\u00e9matologie, Institut Universitaire du Cancer de Toulouse\u2010Oncopole, Centre Hospitalier Universitaire de Toulouse  France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Vergez","sequence":"additional","affiliation":[{"name":"Laboratoire d'H\u00e9matologie, Institut Universitaire du Cancer de Toulouse\u2010Oncopole, Centre Hospitalier Universitaire de Toulouse  France"},{"name":"Universit\u00e9 Paul Sabatier \u2013 Toulouse III Toulouse France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Delas","sequence":"additional","affiliation":[{"name":"Service d'anatomopathologie, Institut Universitaire du Cancer de Toulouse, Centre Hospitalier Universitaire de Toulouse  France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Belliere","sequence":"additional","affiliation":[{"name":"D\u00e9partement de N\u00e9phrologie et Transplantation d'organes Centre Hospitalier Universitaire de Toulouse  France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Protin","sequence":"additional","affiliation":[{"name":"Service d'H\u00e9matologie, Institut Universitaire du Cancer de Toulouse\u2010Oncopole, Centre Hospitalier Universitaire de Toulouse  France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nassim","family":"Kamar","sequence":"additional","affiliation":[{"name":"D\u00e9partement de N\u00e9phrologie et Transplantation d'organes Centre Hospitalier Universitaire de Toulouse  France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In\u00e8s","family":"Ferrandiz","sequence":"additional","affiliation":[{"name":"D\u00e9partement de N\u00e9phrologie et Transplantation d'organes Centre Hospitalier Universitaire de Toulouse  France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Tavitian","sequence":"additional","affiliation":[{"name":"Service d'H\u00e9matologie, Institut Universitaire du Cancer de Toulouse\u2010Oncopole, Centre Hospitalier Universitaire de Toulouse  France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Laurent","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paul Sabatier \u2013 Toulouse III Toulouse France"},{"name":"Service d'anatomopathologie, Institut Universitaire du Cancer de Toulouse, Centre Hospitalier Universitaire de Toulouse  France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Huart","sequence":"additional","affiliation":[{"name":"D\u00e9partement de N\u00e9phrologie et Transplantation d'organes Centre Hospitalier Universitaire de Toulouse  France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Chauveau","sequence":"additional","affiliation":[{"name":"D\u00e9partement de N\u00e9phrologie et Transplantation d'organes Centre Hospitalier Universitaire de Toulouse  France"},{"name":"Universit\u00e9 Paul Sabatier \u2013 Toulouse III Toulouse France"},{"name":"Centre de r\u00e9f\u00e9rence des maladies r\u00e9nales rares, Centre Hospitalier Universitaire deToulouse  France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8478-5623","authenticated-orcid":false,"given":"Lo\u00efc","family":"Ysebaert","sequence":"additional","affiliation":[{"name":"Service d'H\u00e9matologie, Institut Universitaire du Cancer de Toulouse\u2010Oncopole, Centre Hospitalier Universitaire de Toulouse  France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0553-0927","authenticated-orcid":false,"given":"Stanislas","family":"Faguer","sequence":"additional","affiliation":[{"name":"D\u00e9partement de N\u00e9phrologie et Transplantation d'organes Centre Hospitalier Universitaire de Toulouse  France"},{"name":"Universit\u00e9 Paul Sabatier \u2013 Toulouse III Toulouse France"},{"name":"Centre de r\u00e9f\u00e9rence des maladies r\u00e9nales rares, Centre Hospitalier Universitaire deToulouse  France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,12,6]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0095190"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.06760909"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.10611110"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.23413"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.anndiagpath.2015.03.003"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2010.07.009"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5000123"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V1271482"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2009010110"},{"issue":"4","key":"e_1_2_7_11_1","first-page":"527","article-title":"Spectrum of glomerular and tubulointerstitial renal lesions associated with monotypical immunoglobulin light chain deposition","volume":"64","author":"Sanders PW","year":"1991","journal-title":"Lab Invest."},{"issue":"12","key":"e_1_2_7_12_1","doi-asserted-by":"crossref","first-page":"3888","DOI":"10.1093\/ndt\/gfn363","article-title":"Monoclonal immunoglobulin deposition disease associated with membranous features","volume":"23","author":"Komatsuda A","year":"2008","journal-title":"Nephrol Dial Transplant."},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2015020185"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-07-445304"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-05-495929"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428191003682767"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428190902887563"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402676"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2011.591005"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.23798"},{"issue":"2","key":"e_1_2_7_21_1","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1586\/ehm.10.7","article-title":"Bendamustine: new perspective for an old drug in lymphoproliferative disorders","volume":"3","author":"Montillo M","year":"2010","journal-title":"Expert Rev Hematol."},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2013.842986"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61763-2"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.08.100"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.17.0001"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-016-2668-0"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-01-643569"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12102"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-06-093906"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.01600408"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24738"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)00465-9"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)30051-1"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14232"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.23909"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-04-778175"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-016-2146-4"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2015.1012714"},{"issue":"6","key":"e_1_2_7_39_1","first-page":"2827","article-title":"Bendamustin\u2010rituximab combination is a safe and effective, ambulatory treatment for elderly patients with chronic lymphocytic leukemia: retrospective real\u2010world analysis by age from a German Registry and review of the literature","volume":"36","author":"Kleeberg UR","year":"2016","journal-title":"Anticancer Res."},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14279"}],"container-title":["American Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fajh.24984","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ajh.24984","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T16:52:42Z","timestamp":1695574362000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ajh.24984"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,6]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["10.1002\/ajh.24984"],"URL":"https:\/\/doi.org\/10.1002\/ajh.24984","archive":["Portico"],"relation":{},"ISSN":["0361-8609","1096-8652"],"issn-type":[{"value":"0361-8609","type":"print"},{"value":"1096-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,6]]}}}